ELENBECESTAT, E2609, A BACE INHIBITOR: RESULTS FROM A PHASE-2 STUDY IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT AND MILD-TO-MODERATE DEMENTIA DUE TO ALZHEIMER'S DISEASE